Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
2019 14
2020 2770
2021 4597
2022 4049
2023 22
Text availability
Article attribute
Article type
Publication date

Search Results

10,386 results
Results by year
Filters applied: . Clear all
Page 1
Coronavirus disease 2019 (COVID-19): An overview of the immunopathology, serological diagnosis and management.
Anka AU, Tahir MI, Abubakar SD, Alsabbagh M, Zian Z, Hamedifar H, Sabzevari A, Azizi G. Anka AU, et al. Scand J Immunol. 2021 Apr;93(4):e12998. doi: 10.1111/sji.12998. Epub 2020 Dec 3. Scand J Immunol. 2021. PMID: 33190302 Free PMC article. Review.
SARS-CoV-2 is a novel human coronavirus responsible for the Coronavirus disease 2019 (COVID-19) pandemic. Pneumonia and acute respiratory distress syndrome are the major complications of COVID-
SARS-CoV-2 is a novel human coronavirus responsible for the Coronavirus disease 2019 (COVID
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study.
Lopez Bernal J, Andrews N, Gower C, Robertson C, Stowe J, Tessier E, Simmons R, Cottrell S, Roberts R, O'Doherty M, Brown K, Cameron C, Stockton D, McMenamin J, Ramsay M. Lopez Bernal J, et al. BMJ. 2021 May 13;373:n1088. doi: 10.1136/bmj.n1088. BMJ. 2021. PMID: 33985964 Free PMC article.
INTERVENTIONS: Vaccination with BNT162b2 or ChAdOx1-S. MAIN OUTCOME MEASURES: Primary outcomes were polymerase chain reaction confirmed symptomatic SARS-CoV-2 infections, admissions to hospital for covid-19, and deaths with covid- …
INTERVENTIONS: Vaccination with BNT162b2 or ChAdOx1-S. MAIN OUTCOME MEASURES: Primary outcomes were polymerase chain reaction confirm …
The emergence of COVID-19 as a global pandemic: Understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2.
Muralidar S, Ambi SV, Sekaran S, Krishnan UM. Muralidar S, et al. Biochimie. 2020 Dec;179:85-100. doi: 10.1016/j.biochi.2020.09.018. Epub 2020 Sep 22. Biochimie. 2020. PMID: 32971147 Free PMC article. Review.
An acute respiratory disease caused by a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that surfaced in China in late 2019, continues to spread rapidly across the globe causing seri …
An acute respiratory disease caused by a severe acute respiratory syndrome coronavirus 2
COVID-19: Transmission, prevention, and potential therapeutic opportunities.
Lotfi M, Hamblin MR, Rezaei N. Lotfi M, et al. Clin Chim Acta. 2020 Sep;508:254-266. doi: 10.1016/j.cca.2020.05.044. Epub 2020 May 29. Clin Chim Acta. 2020. PMID: 32474009 Free PMC article. Review.
The novel coronavirus disease (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), remains a global challenge. ...In this review, current therapeutic option …
The novel coronavirus disease (COVID-19) pandemic, caused by severe acute respiratory syndrome
Coronavirus Disease (COVID-19): Current Status and Prospects for Drug and Vaccine Development.
Ita K. Ita K. Arch Med Res. 2021 Jan;52(1):15-24. doi: 10.1016/j.arcmed.2020.09.010. Epub 2020 Sep 10. Arch Med Res. 2021. PMID: 32950264 Free PMC article. Review.
The Coronavirus disease 2019 (COVID-19) pandemic has spread to almost all nooks and corners of the world. ...This review focuses on the drugs and vaccines being developed against the COVID-19....
The Coronavirus disease 2019 (COVID-19) pandemic has spread to almost all nooks and corners of the world. ...Thi …
6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.
Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, Kang L, Guo L, Liu M, Zhou X, Luo J, Huang Z, Tu S, Zhao Y, Chen L, Xu D, Li Y, Li C, Peng L, Li Y, Xie W, Cui D, Shang L, Fan G, Xu J, Wang G, Wang Y, Zhong J, Wang C, Wang J, Zhang D, Cao B. Huang C, et al. Lancet. 2021 Jan 16;397(10270):220-232. doi: 10.1016/S0140-6736(20)32656-8. Epub 2021 Jan 8. Lancet. 2021. PMID: 33428867 Free PMC article.
Enrolled patients who had participated in the Lopinavir Trial for Suppression of SARS-CoV-2 in China received severe acute respiratory syndrome coronavirus 2 antibody tests. ...INTERPRETATION: At 6 months after acu
Enrolled patients who had participated in the Lopinavir Trial for Suppression of SARS-CoV-2 in China received severe
Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines.
Fernandes Q, Inchakalody VP, Merhi M, Mestiri S, Taib N, Moustafa Abo El-Ella D, Bedhiafi T, Raza A, Al-Zaidan L, Mohsen MO, Yousuf Al-Nesf MA, Hssain AA, Yassine HM, Bachmann MF, Uddin S, Dermime S. Fernandes Q, et al. Ann Med. 2022 Dec;54(1):524-540. doi: 10.1080/07853890.2022.2031274. Ann Med. 2022. PMID: 35132910 Free PMC article. Review.
Novel vaccines and drugs are constantly being developed to unleash an immune response for the robust targeting of SARS-CoV-2 and its associated variants. ...In addition, we also discuss the development, formulation, working mechanisms, advantage …
Novel vaccines and drugs are constantly being developed to unleash an immune response for the robust targeting of SARS- …
Current state of vaccine development and targeted therapies for COVID-19: impact of basic science discoveries.
Marian AJ. Marian AJ. Cardiovasc Pathol. 2021 Jan-Feb;50:107278. doi: 10.1016/j.carpath.2020.107278. Epub 2020 Sep 2. Cardiovasc Pathol. 2021. PMID: 32889088 Free PMC article. Review.
Coronavirus disease-19 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 is closely related to two other coronaviruses th
Coronavirus disease-19 (COVID-19) is caused by severe acute respiratory syndrome
Virology, pathogenesis, diagnosis and in-line treatment of COVID-19.
Samudrala PK, Kumar P, Choudhary K, Thakur N, Wadekar GS, Dayaramani R, Agrawal M, Alexander A. Samudrala PK, et al. Eur J Pharmacol. 2020 Sep 15;883:173375. doi: 10.1016/j.ejphar.2020.173375. Epub 2020 Jul 17. Eur J Pharmacol. 2020. PMID: 32682788 Free PMC article. Review.
SARS-CoV-2, a newly emerged pathogen in December 2019, marked as one of the highly pathogenic Coronavirus, and altogether this is the third coronavirus attack that crossed the species barrier. ...Spike glycoprotein promotes the entry of t
SARS-CoV-2, a newly emerged pathogen in December 2019, marked as one of the highly pathogenic Coronavirus
Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19.
Yadav R, Chaudhary JK, Jain N, Chaudhary PK, Khanra S, Dhamija P, Sharma A, Kumar A, Handu S. Yadav R, et al. Cells. 2021 Apr 6;10(4):821. doi: 10.3390/cells10040821. Cells. 2021. PMID: 33917481 Free PMC article. Review.
Strikingly, novel coronavirus (2019-nCoV), later renamed as severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), and found to be the causative agent of coronavirus disease-19
Strikingly, novel coronavirus (2019-nCoV), later renamed as severe acute respiratory syndrome
10,386 results
You have reached the last available page of results. Please see the User Guide for more information.